Table 2 Association of a history of Type 2 DM and first event cardiovascular
T2DM (event/N) | Effect | Breslow-Day homogeneity test | |||||
|---|---|---|---|---|---|---|---|
No | Yes | OR | IC95 | ||||
Sex | |||||||
Women | 207/12741 | 370/12644 | 1.825 | 1.532 | 2.176 | 0.452 | 0.056 |
Men | 196/5708 | 280/5805 | 1.425 | 1.178 | 1.725 | 0.298 | |
Age | |||||||
< 65 years | 136/9807 | 196/9719 | 1.464 | 1.168 | 1.838 | 0.317 | 0.238 |
> =65 years | 267/8642 | 454/8730 | 1.721 | 1.471 | 2.014 | 0.419 | |
CKD | |||||||
No | 308/15409 | 503/15415 | 1.654 | 1.429 | 1.914 | 0.395 | 0.760 |
Yes | 95/3040 | 147/3034 | 1.578 | 1.205 | 2.076 | 0.366 | |
Controlled Hypertension | |||||||
No | 47/1797 | 76/1747 | 1.693 | 1.154 | 2.505 | 0.409 | 0.847 |
Yes | 356/16652 | 574/16702 | 1.629 | 1.422 | 1.867 | 0.386 | |
Dyslipidemia | |||||||
No | 18/2493 | 33/2466 | 1.865 | 1.016 | 3.526 | 0.464 | 0.647 |
Yes | 385/15956 | 617/15983 | 1.624 | 1.424 | 1.852 | 0.384 | |
Obesity | |||||||
No | 242/9171 | 385/9134 | 1.624 | 1.374 | 1.918 | 0.384 | 0.873 |
Yes | 161/9278 | 265/9315 | 1.658 | 1.354 | 2.034 | 0.397 | |
Hypertension | |||||||
No | 1/534 | 0/514 | 0.2095a | ||||
Yes | 402/17915 | 650/17935 | 1.638 | 1.441 | 1.862 | 0.390 | |
ACEI-ARB | |||||||
No | 37/6374 | 47/6377 | 1.272 | 0.808 | 2.015 | 0.214 | 0.225 |
Yes | 366/12075 | 603/12072 | 1.682 | 1.470 | 1.924 | 0.405 | |
Calcium Antagonist | |||||||
No | 169/12673 | 269/12632 | 1.610 | 1.320 | 1.964 | 0.379 | 0.815 |
Yes | 234/5776 | 381/5817 | 1.660 | 1.400 | 1.969 | 0.398 | |
Statins | |||||||
No | 61/9126 | 92/9067 | 1.523 | 1.089 | 2.143 | 0.344 | 0.632 |
Yes | 342/9323 | 558/9382 | 1.661 | 1.444 | 1.910 | 0.398 | |
Antiplatelet | |||||||
No | 95/11207 | 144/11102 | 1.537 | 1.176 | 2.016 | 0.349 | 0.599 |
Yes | 308/7242 | 506/7347 | 1.665 | 1.436 | 1.931 | 0.399 | |
Number antihypertensive drugs | |||||||
< 2 | 49/9062 | 68/9421 | 1.337 | 0.912 | 1.973 | 0.252 | 0.172 |
> =2 | 354/9387 | 582/9028 | 1.758 | 1.532 | 2.018 | 0.431 | |